Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: J Child Neurol. 2012 Jun 29;27(9):1133–1137. doi: 10.1177/0883073812448230

Clinical Features of Friedreich Ataxia

Martin B Delatycki 1,2,3, Louise A Corben 1
PMCID: PMC3674491  NIHMSID: NIHMS473276  PMID: 22752493

Abstract

Friedreich ataxia, the most common hereditary ataxia, affects about 1:29 000 Caucasians. In about 98% of these individuals it is due to homozygosity for a GAA trinucleotide repeat expansion in intron 1 of FXN; in the other 2% it is due to compound heterozygosity for a GAA expansion and point mutation or deletion. The condition affects multiple sites in the central and peripheral nervous system as well as a number of other organ systems, resulting in multiple signs and symptoms. Onset of this autosomal recessive condition is usually in the first 2 decades of life. Major clinical features include progressive ataxia, absent lower limb reflexes, upgoing plantar responses, and peripheral sensory neuropathy. The main non-neurological sites of morbidity are the heart, resulting in cardiomyopathy, and the pancreas, resulting in diabetes mellitus. In this review, we provide an overview of the clinical features of Friedreich ataxia and discuss differential diagnoses.

Keywords: Friedreich ataxia, neuropathy, spinocerebellar, cerebellum, cardiomyopathy, diabetes mellitus


Nikolaus Friedreich first described Friedreich ataxia in a series of 5 papers published from 1863 to 1877.15 Friedreich recognized many of the main features of the disorder subsequently named after him, including an onset most often occurring in adolescence, ataxia, sensory neuropathy, scoliosis, foot deformity, and cardiomyopathy. During the next 100 years, precisely what comprises the clinical spectrum of Friedreich ataxia was the subject of some confusion and debate. With discovery of the causative gene in 1996,6 FXN (previously called X25 and FRDA), rapid and accurate diagnosis of Friedreich ataxia can now be made in most instances. This has allowed studies to accurately assess clinical features of the condition. Almost all with Friedreich ataxia (~98%) have homozygous expansions of an intron 1 GAA trinucleotide repeat in FXN as the causative mutation; the other 2% are compound heterozygous for a GAA repeat expansion and a point mutation or deletion. The size of the smaller repeat correlates with the presence of a number of clinical features and negatively correlates with age at onset, but repeat size cannot be accurately used to predict prognosis in an individual.710

Friedreich ataxia most commonly affects individuals of Caucasian descent. It is very rare in those from Southeast Asia and Africa. It accounts for about half of all genetic ataxia and three quarters of inherited ataxia in people under 25 years.11 On the basis of molecular studies, the estimated incidence of Friedreich ataxia in Caucasians is about 1 in 29 000, with a carrier frequency of 1 in 85.12 Because the inheritance of Friedreich ataxia is autosomal recessive, it generally affects one or more members of a sibship but rarely affects more than one generation of a family.

The first attempt to define diagnostic criteria was by Geoffroy and colleagues (Table 1).13 Harding proposed less stringent criteria in 1981 (Table 2).14 With the discovery of the causative gene, these criteria have proved to be very specific but not particularly sensitive, with about 25% of affected individuals not fulfilling these criteria.

Table 1.

Diagnostic Criteria Proposed by Geoffroy and Colleagues in 197613

Primary (must be present)
  • onset before the end of puberty (never after 20 years)

  • progressive ataxia of gait

  • dysarthria

  • loss of joint position or vibration sense

  • absent tendon reflexes in the legs

  • muscle weakness

Secondary
  • extensor plantar responses

  • pes cavus

  • scoliosis

  • cardiomyopathy

Table 2.

Diagnostic Criteria Proposed by Harding in 198114

Primary (must be present)
  • onset before 25 years

  • progressive ataxia of limbs and gait

  • absence of knee and ankle jerks

Secondary
  • dysarthria

  • extensor plantar responses

If secondary criteria are absent, the following have to be present: (1) an affected sib fulfilling primary and secondary criteria, (2) median motor nerve conduction velocities of greater than 40 m/s, thus excluding cases of type 1 hereditary motor and sensory neuropathy.

Friedreich Ataxia Due to Homozygous FXN Intron 1 GAA Expansions

Onset and Progression

Friedreich ataxia typically presents prior to 25 years, with the average age of symptom onset occurring in the early to mid-teen years.7,8 Atypical Friedreich ataxia refers to disease that does not meet classical criteria. There are 2 main atypical presentations: Friedreich ataxia with retained reflexes and late-onset Friedreich ataxia. Friedreich ataxia with retained reflexes often presents with brisk lower limb reflexes, particularly knee jerks, and is found in about 9% of affected individuals.15 Late-onset Friedreich ataxia, characterized by symptom onset after 25 years, is found in about 14%,8,16 while very late-onset Friedreich ataxia, characterized by onset after 40 years, is very rare.17

Friedreich ataxia is a relatively slowly progressive disorder. Average time from onset to requiring a wheelchair for mobility is about 10 years.7,8 Three studies have looked at mortality in Friedreich ataxia. Harding found the average age at death was 37 years,14 whereas De Michele and colleagues found that average time from onset to death was 36 years.18 A recent study involving 61 participants reported that the mean age at death was 37.5 years, while the median was 30 years.19 Causes of death were as follows: cardiac dysfunction (59%), probable cardiac dysfunction (3.3%), non-cardiac (27.9%), and unknown (9.8%).

Neurological and Neuromuscular Manifestations of Friedreich ataxia

Major clinical features of Friedreich ataxia and their frequency are shown in Table 3. Progressive trunk and limb ataxia, dysarthria, and muscle weakness are almost invariably present. Ataxia is by far the most common presenting symptom in Friedreich ataxia and is due to a combination of cerebellar and spinocerebellar degeneration, sensory neuropathy, and vestibular nerve involvement. Axonal neuropathy usually results in absent lower limb reflexes in the presence of upgoing plantar responses that are caused by degeneration of the corticospinal tracts in the spinal cord. A peripheral sensory neuropathy is common and reduced/absent vibration sense and proprioception result from degeneration of the posterior columns of the spinal cord. In addition, cold, cyanosed distal lower limbs due to autonomic disturbance may be seen, particularly in the latter stages of disease.11

Table 3.

Major Clinical Features of FRDA and Their Frequency from 3 Studies47

Symptom Harding14 Durr8 Delatycki7
Ataxia 99 100 100
Dysarthria 97 91 95
Absent lower limb reflexes 99 87 74
Scoliosis 79 60 78
Pes cavus 55 55 74
Swallowing disturbance - 27 -
Sphincter disturbance - 23 41
Reduced vision 18 13 -
Hearing impairment 8 13 -
Cardiomyopathy on echocardiogram - 63 65
Diabetes/abnormal glucose tolerance 10 32 8

Scoliosis is present in most of those with Friedreich ataxia, with a high prevalence of double thoracic and lumbar curves.2022 In one study, 20% of individuals with Friedreich ataxia required the prescription of a brace and 33% required spinal fusion.21 Pes cavus is common, occurring in 55% to 75% of individuals with Friedreich ataxia (Table 3), but it rarely causes morbidity. Equinovarus deformity of the feet is more commonly a cause of morbidity. In one study, equinovarus deformity that was of moderate severity but was reducible was diagnosed in 8 of 32 subjects, and severe non-reducible deformity was present in 9 of 32.23

Vision can be affected by a number of pathological processes. In one large study,8 13% of people with Friedreich ataxia were found to have visual loss, and 30% had optic atrophy14 Fortuna and colleagues found 26 of 26 individuals with Friedreich ataxia had anterior and posterior visual pathway abnormalities when assessed by optical coherence tomography and pattern visual evoked potentials, and all had reduced retinal nerve fiber layer thickness. Only 5 of 26 had visual symptoms, however.24 Sudden loss of vision similar to that which occurs in Leber hereditary optic neuropathy is a well-described, albeit rare event in Friedreich ataxia. Abnormalities of eye movements are very common in Friedreich ataxia. The most commonly seen are square wave jerks; abnormalities of saccades, pursuit, fixation, and vestibular-ocular reflex are also commonly seen.25 As a result of the impact of Friedreich ataxia on the visual system, visual quality of life is reduced in affected individuals.

Dysarthria is present in more than 90% of individuals affected by Friedreich ataxia (see Table 3). In a study of dysarthria in 38 individuals with the condition, 3 symptom subgroups were identified: (1) mild dysarthric symptoms, (2) increased velopharyngeal involvement, and (3) increased laryngeal dysfunction.26 Severity of dysarthria was found to correlate with disease duration. Dysphagia is problematic for some individuals with Friedreich ataxia, particularly in the latter stages of disease; however, there are no systematic studies of this aspect of the condition. Aspiration pneumonia secondary to dysphagia is an important cause of morbidity and mortality.

Hearing loss is found in 8% to 13% of individuals with Friedreich ataxia (see Table 3). When hearing in conditions of background noise is assessed (which is a more realistic measure of real-life hearing than testing with no background noise), hearing problems are very common in Friedreich ataxia.27,28 Auditory neuropathy affects a significant minority. The use of FM-listening devices has been shown to improve hearing and communication.29

Friedreich ataxia was traditionally thought not to affect cognition; however, more recent studies have shown that specific aspects of cognitive function are affected in many. Mantovan and colleagues found that the average IQ of people with Friedreich ataxia (92.8) was not significantly different than that noted in controls (110.8).30 However, examination of the neurobehavioral profile of participants with Friedreich ataxia revealed impairment in verbal fluency, visuoconstructive and visuoperceptual capacity, and motor and mental reaction times. Mantovan and colleagues concluded that the intelligence profile of individuals with Friedreich ataxia is characterized by concrete thinking, poor capacity in concept formation, and visuospatial reasoning with reduced speed of information processing. More recent studies have also reported individuals with Friedreich ataxia are significantly disadvantaged in accommodating unexpected movement, initiating movement without a direct visual cues, and reacting to incongruent, compared with congruent, stimuli.3134 Moreover, impairment in the cognitive control of ocular movement35,36 and difficulty with attention and working memory have also been demonstrated.37

As with most neurodegenerative conditions, affective disorders are more commonly seen in those with Friedreich ataxia than in healthy controls. Flood and Perlman38 found 35 of 38 individuals with Friedreich ataxia had an affective disorder, ranging from a grief reaction to major depression. In a small study, personality profiles outside the normal range — including poor impulse control, irritability, and blunting of affect — were noted.30

Urological symptoms are common in Friedreich ataxia. In a cohort of people with Friedreich ataxia followed in Melbourne, 78 of 133 (59%) reported some problems with bladder function (unpublished data). These problems include hesitancy, urgency, retention, and incontinence. The requirement for an in-dwelling catheter is rare.

Other Major Clinical Features of FRDA

Cardiomyopathy is found in most people with Friedreich ataxia. This may result in symptoms of heart failure or palpitations but is often asymptomatic.39 An abnormal electrocardiogram is found in almost all and in particular T wave inversion, left-axis deviation, and repolarization abnormalities are common.40 Hypertrophic cardiomyopathy is seen on echocardiography in around 65% in cross-sectional studies (see Table 3), whereas almost all will have abnormalities when more subtle assessments such as Doppler ultrasound41 and magnetic resonance imaging are used.42 Septal and lateral long-axis dysfunction is common.41 Cardiac wall thickness often decreases as disease progresses42 and dilated cardiomyopathy may be seen, generally late in the disease course. Arrhythmias are common and can result in sudden death. Ejection fraction tends to remain normal until late in the disease course, with reduced ejection fraction being found in 20% of a large cohort.43 Rarely, cardiomyopathy presents before ataxia develops.

Diabetes mellitus is present in 10% to 30% of people with Friedreich ataxia and impaired glucose tolerance is seen in a significant minority of others.7,8 Although impaired glucose metabolism in Friedreich ataxia is due to insulin resistance rather than insulin deficit, insulin therapy is usually required where diabetes mellitus occurs.

FRDA Due to Point Mutations and Deletions

As noted above, about 2% of Friedreich ataxia is due to compound heterozygosity for an intron 1 GAA expansion and a point mutation or deletion in FXN. The phenotype seen in individuals with some point mutations is indecipherable from that in those homozygous for FXN GAA expansions, but for others the phenotype differs.44 p.Gly130Val is the most common point mutation and, compared with those with homozygous GAA expansions, individuals with this mutation generally have a later age of onset, slower disease progression, marked lower limb spasticity, and absent dysarthria and cardiomyopathy.45

Differential Diagnosis

Friedreich ataxia is a condition with considerable variation in the extent of morbidity and mortality. Nevertheless, the clinical diagnosis of typical Friedreich ataxia is usually reasonably distinct, although early in the course there may be insufficient clinical features present to be certain. Atypical Friedreich ataxia and Friedreich ataxia due to compound heterozygosity for a FXN GAA expansion and a point mutation may present a greater diagnostic dilemma. Conditions that need to be considered in the differential diagnosis of FRDA include but are not limited to: (1) Ataxia — ataxia with vitamin E deficiency, ataxia with oculomotor apraxia types 1 and 2, ataxia telangiectasia, late-onset Tay-Sachs disease, ataxia due to mitochondrial DNA mutations; (2) Peripheral neuropathy — hereditary motor and sensory neuropathy, and (3) Spasticity — hereditary spastic paraparesis.46

Acknowledgments

M.B.D. is a Practitioner Fellow and L.A.C. is an Early Career Fellow, both of the National Health and Medical Research Council. Supported by grants from the National Institutes of Health (2R13NS040925-14 Revised), the National Institutes of Health Office of Rare Diseases Research, the Child Neurology Society, and the National Ataxia Foundation. We thank Melanie Fridl Ross, MSJ, ELS, for editing assistance.

Footnotes

This paper is based on a presentation given at the Neurobiology of Disease in Children Symposium: Childhood Ataxia, in conjunction with the 40thAnnual Meeting of the Child Neurology Society, Savannah, Georgia, October 26, 2011.

References

  • 1.Friedreich N. Uber degenerative Atrophie der spinalen Hinterstrange. Virchow’s Arch Pathol Anat. 1863;26:391–419. [Google Scholar]
  • 2.Friedreich N. Uber degenerative Atrophie der spinalen Hinterstrange. Virchow’s Arch Pathol Anat. 1863;26:433–459. [Google Scholar]
  • 3.Friedreich N. Uber degenerative Atrophie der spinalen Hinterstrange. Virchow’s Arch Pathol Anat. 1863;27:1–26. [Google Scholar]
  • 4.Friedreich N. Uber ataxie mit besonderer berucksichtigung der hereditaren formen. Virchow’s Arch Pathol Anat. 1876;68:145–245. [Google Scholar]
  • 5.Friedreich N. Uber ataxie mit besonderer berucksichtigung der hereditaren formen. Virchow’s Arch Pathol Anat. 1877;70:140–152. [Google Scholar]
  • 6.Campuzano V, Montermini L, Molto MD, et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271:1423–1427. doi: 10.1126/science.271.5254.1423. [DOI] [PubMed] [Google Scholar]
  • 7.Delatycki MB, Paris DB, Gardner RJ, et al. Clinical and genetic study of Friedreich ataxia in an Australian population. Am J Med Genet. 1999;87:168–174. doi: 10.1002/(sici)1096-8628(19991119)87:2<168::aid-ajmg8>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  • 8.Durr A, Cossee M, Agid Y, et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med. 1996;335:1169–1175. doi: 10.1056/NEJM199610173351601. [DOI] [PubMed] [Google Scholar]
  • 9.Filla A, De Michele G, Cavalcanti F, et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet. 1996;59:554–560. [PMC free article] [PubMed] [Google Scholar]
  • 10.Montermini L, Richter A, Morgan K, et al. Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann Neurol. 1997;41:675–682. doi: 10.1002/ana.410410518. [DOI] [PubMed] [Google Scholar]
  • 11.Pandolfo M. Friedreich ataxia: the clinical picture. J Neurol. 2009;256(Suppl 1):3–8. doi: 10.1007/s00415-009-1002-3. [DOI] [PubMed] [Google Scholar]
  • 12.Cossee M, Schmitt M, Campuzano V, et al. Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. Proc Natl Acad Sci U S A. 1997;94:7452–7457. doi: 10.1073/pnas.94.14.7452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Geoffroy G, Barbeau A, Breton G, et al. Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia. Can J Neurol Sci. 1976;3:279–286. doi: 10.1017/s0317167100025464. [DOI] [PubMed] [Google Scholar]
  • 14.Harding AE. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain. 1981;104:589–620. doi: 10.1093/brain/104.3.589. [DOI] [PubMed] [Google Scholar]
  • 15.Palau F, De Michele G, Vilchez JJ, et al. Early-onset ataxia with cardiomyopathy and retained tendon reflexes maps to the Friedreich's ataxia locus on chromosome 9q. Ann Neurol. 1995;37:359–362. doi: 10.1002/ana.410370312. [DOI] [PubMed] [Google Scholar]
  • 16.Bhidayasiri R, Perlman SL, Pulst SM, Geschwind DH. Late-onset Friedreich ataxia: phenotypic analysis, magnetic resonance imaging findings, and review of the literature. Arch Neurol. 2005;62:1865–1869. doi: 10.1001/archneur.62.12.1865. [DOI] [PubMed] [Google Scholar]
  • 17.Berciano J, Infante J, Garcia A, et al. Very late-onset Friedreich's ataxia with minimal GAA1 expansion mimicking multiple system atrophy of cerebellar type. Mov Disord. 2005;20:1643–1645. doi: 10.1002/mds.20644. [DOI] [PubMed] [Google Scholar]
  • 18.De Michele G, Perrone F, Filla A, et al. Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich's disease: a retrospective study on 119 patients. Neurology. 1996;47:1260–1264. doi: 10.1212/wnl.47.5.1260. [DOI] [PubMed] [Google Scholar]
  • 19.Tsou AY, Paulsen EK, Lagedrost SJ, et al. Mortality in Friedreich ataxia. J Neurol Sci. 2011;307:46–49. doi: 10.1016/j.jns.2011.05.023. [DOI] [PubMed] [Google Scholar]
  • 20.Labelle H, Tohme S, Duhaime M, Allard P. Natural history of scoliosis in Friedreich's ataxia. J Bone Joint Surg Am. 1986;68:564–572. [PubMed] [Google Scholar]
  • 21.Milbrandt TA, Kunes JR, Karol LA. Friedreich's ataxia and scoliosis: the experience at two institutions. J Pediatr Orthop. 2008;28:234–238. doi: 10.1097/BPO.0b013e318164fa79. [DOI] [PubMed] [Google Scholar]
  • 22.Shapiro F, Specht L. The diagnosis and orthopaedic treatment of childhood spinal muscular atrophy, peripheral neuropathy, Friedreich ataxia, and arthrogryposis. J Bone Joint Surg. Am. 1993;75:1699–1714. doi: 10.2106/00004623-199311000-00017. [DOI] [PubMed] [Google Scholar]
  • 23.Delatycki MB, Holian A, Corben L, et al. Surgery for equinovarus deformity in Friedreich's ataxia improves mobility and independence. Clin Orthop Relat Res. 2005;430:138–141. doi: 10.1097/01.blo.0000150339.74041.0e. [DOI] [PubMed] [Google Scholar]
  • 24.Fortuna F, Barboni P, Liguori R, et al. Visual system involvement in patients with Friedreich's ataxia. Brain. 2009;132:116–123. doi: 10.1093/brain/awn269. [DOI] [PubMed] [Google Scholar]
  • 25.Fahey MC, Cremer PD, Aw ST, et al. Vestibular, saccadic and fixation abnormalities in genetically confirmed Friedreich ataxia. Brain. 2008;131:1035–1045. doi: 10.1093/brain/awm323. [DOI] [PubMed] [Google Scholar]
  • 26.Folker J, Murdoch B, Cahill L, et al. Dysarthria in Friedreich's ataxia: a perceptual analysis. Folia Phoniatr Logop. 2010;62:97–103. doi: 10.1159/000287207. [DOI] [PubMed] [Google Scholar]
  • 27.Rance G, Corben L, Barker E, et al. Auditory perception in individuals with Friedreich's ataxia. Audiol Neurootol. 2009;15:229–240. doi: 10.1159/000255341. [DOI] [PubMed] [Google Scholar]
  • 28.Rance G, Fava R, Baldock H, et al. Speech perception ability in individuals with Friedreich ataxia. Brain. 2008;131:2002–2012. doi: 10.1093/brain/awn104. [DOI] [PubMed] [Google Scholar]
  • 29.Rance G, Corben LA, Du Bourg E, et al. Successful treatment of auditory perceptual disorder in individuals with Friedreich ataxia. Neuroscience. 2010;171(2):552–555. doi: 10.1016/j.neuroscience.2010.09.013. [DOI] [PubMed] [Google Scholar]
  • 30.Mantovan MC, Martinuzzi A, Squarzanti F, et al. Exploring mental status in Friedreich's ataxia: a combined neuropsychological, behavioral and neuroimaging study. Eur J Neurol. 2006;13:827–835. doi: 10.1111/j.1468-1331.2006.01363.x. [DOI] [PubMed] [Google Scholar]
  • 31.Corben LA, Akhlaghi H, Georgiou-Karistianis N, et al. Impaired inhibition of prepotent motor tendencies in Friedreich ataxia demonstrated by the Simon interference task. Brain Cogn. 2011;76:140–145. doi: 10.1016/j.bandc.2011.02.002. [DOI] [PubMed] [Google Scholar]
  • 32.Corben LA, Delatycki MB, Bradshaw JL, et al. Utilisation of advance motor information is impaired in Friedreich ataxia. Cerebellum. 2011;10:793–803. doi: 10.1007/s12311-011-0289-7. [DOI] [PubMed] [Google Scholar]
  • 33.Corben LA, Delatycki MB, Bradshaw JL, et al. Impairment in motor reprogramming in Friedreich ataxia reflecting possible cerebellar dysfunction. J Neurol. 2010;257:782–791. doi: 10.1007/s00415-009-5410-1. [DOI] [PubMed] [Google Scholar]
  • 34.Corben LA, Georgiou-Karistianis N, Bradshaw JL, et al. The Fitts task reveals impairments in planning and online control of movement in Friedreich ataxia: reduced cerebellar-cortico connectivity? Neuroscience. 2011;192:382–390. doi: 10.1016/j.neuroscience.2011.06.057. [DOI] [PubMed] [Google Scholar]
  • 35.Fielding J, Corben L, Cremer P, et al. Disruption to higher order processes in Friedreich ataxia. Neuropsychologia. 2010;48:235–242. doi: 10.1016/j.neuropsychologia.2009.09.009. [DOI] [PubMed] [Google Scholar]
  • 36.Hocking DR, Fielding J, Corben LA, et al. Ocular motor fixation deficits in Friedreich ataxia. Cerebellum. 2010;9:411–418. doi: 10.1007/s12311-010-0178-5. [DOI] [PubMed] [Google Scholar]
  • 37.Klopper F, Delatycki MB, Corben LA, et al. The test of everyday attention reveals significant sustained volitional attention and working memory deficits in friedreich ataxia. J Int Neuropsychol Soc. 2011;17:196–200. doi: 10.1017/S1355617710001347. [DOI] [PubMed] [Google Scholar]
  • 38.Flood MK, Perlman SL. The mental status of patients with Friedreich's ataxia. J Neurosci Nurs. 1987;19:251–255. doi: 10.1097/01376517-198710000-00006. [DOI] [PubMed] [Google Scholar]
  • 39.Payne RM, Pride PM, Babbey CM. Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development. Pediatr Cardiol. 2011;32:366–378. doi: 10.1007/s00246-011-9943-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Dutka DP, Donnelly JE, Nihoyannopoulos P, et al. Marked variation in the cardiomyopathy associated with Friedreich's ataxia. Heart. 1999;81:141–147. doi: 10.1136/hrt.81.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Mottram PM, Delatycki MB, Donelan L, et al. Early changes in left ventricular long-axis function in Friedreich ataxia: relation with the FXN gene mutation and cardiac structural change. J Am Soc Echocardiogr. 2011;24:782–789. doi: 10.1016/j.echo.2011.04.004. [DOI] [PubMed] [Google Scholar]
  • 42.Rajagopalan B, Francis JM, Cooke F, et al. Analysis of the factors influencing the cardiac phenotype in Friedreich's ataxia. Mov Disord. 2010;25:846–852. doi: 10.1002/mds.22864. [DOI] [PubMed] [Google Scholar]
  • 43.Regner SR, Lagedrost SJ, Plappert T, et al. Analysis of echocardiograms in a large heterogeneous cohort of patients with Friedreich ataxia. Am J Cardiol. 2012;109:401–405. doi: 10.1016/j.amjcard.2011.09.025. [DOI] [PubMed] [Google Scholar]
  • 44.Cossee M, Durr A, Schmitt M, et al. Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol. 1999;45:200–206. doi: 10.1002/1531-8249(199902)45:2<200::aid-ana10>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  • 45.Delatycki MB, Knight M, Koenig M, et al. G130V, a common FRDA point mutation, appears to have arisen from a common founder. Hum Genet. 1999;105:343–346. doi: 10.1007/s004399900142. [DOI] [PubMed] [Google Scholar]
  • 46.Bidichandani S, Delatycki M. Friedreich ataxia. Gene Tests. 2009 http://www.ncbi.nlm.nih.gov/books/NBK1281/
  • 47.Delatycki MB, Williamson R, Forrest SM. Friedreich ataxia: an overview. J Med Genet. 2000;37:1–8. doi: 10.1136/jmg.37.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES